Myeloid malignancy Flashcards

1
Q

What groups of blood cancers fall under the myeloid malignancies?

What cells are myeloid cells ie what cells are implicated in myeloid malignancies?

A

AML - Acute Myeloid Leukaemias

Myeloproliferative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Myeloid malignancies are caused by mutations in what cells?

A

Haematopoietic stem cells

Rarely in early progenitor cells

Different mutations will cause different myeloid malignancies down the line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the main groups of myeloid malignancy?

A

AML - Acute myeloid leakaemia

CML - Chronic myeloid leukaemia

MDS - Myelodysplastic syndromes

MPN - Myeloproliferative neoplasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the differences between acute and chronic leukaemia, in terms of:

a) differentiation of cells
b) effects on bone marrow
c) speed of onset/decline

A

a) In Acute leukaemias - there is no differentiation of progenitor cells but in chronic - there is
b) In acute leukaemia - proliferation occurs in and takes over the bone marrow leading to rapid bone marrow failure. In chronic leukaemia, there is proliferation without bone marrow failure
c) Acute leukaemia symptoms develop in a matter of weeks/months whereas Chronic leukaemias develop much slower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical features of AML?

A

Bone marrow failure triad:

Anaemia

Thrombocytopenic bleeding (purpura & mucosal membrane bleeds)

Infection (bacterial and fungal esp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the essential investigations for AML?

A

Blood count and blood film:

  • cytopenia
    • anaemia
    • thrombocytopenia
    • neutropenia

Bone marrow aspirate / trephine:

  • AML & ALL - diagnosed if >20% blast cells

Cytogenetic (karyotype) of blast cells

Immunophenotyping of blasts (determine in AML or ALL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give an overview of the treatment of AML?

A

Supportive care

Anti-leukaemic chemotherapy:

  1. Remission induction (1-2 cycles)
  2. Consolidation (1-3 cycles)
  3. Maintenance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is Acute promyelocytic leukaemia treated?

A

ATRA & ATO

(All-trans retinoic acid & arsenic trioxide)

Chemo-free and 90% curative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe anti-leukaemic chemotherapy for AML

A

Anti-leukaemic chemotherapy for AML has 3 distinct phases…

1) Remission induction:

  • remission = normal blood count & <5% blasts
  • 1-2 cycles of chemotherapy

2) Consolidation (1-3 cycles):

  • patients recieve chemotherapy and then…
  • Allogeneic stem cell transplantation

3) Maintenance:

  • targeted therapies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the clinical features of Chronic myeloid leukaemia?

A

Anaemia

Splenomegaly

Weight loss

Hyperleukostasis

Gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hyperleukostasis is one of the key clinical features of CML

What does this mean?

A

This is caused by high white cell counts and is characterised by:

  • fundal haemorrhage
  • venous congestion
  • altered consciousness
  • respiratory failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What features of a blood count might indicate CML?

What cells would be present in the blood that are not normally present?

A

WBCs - elevated

RBCs - depressed

Platelets - elevated

Presence of bone marrow cells in blood - such as blasts, promyelocytes etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What key feature is present in bone marrow and blood cells in patients with CML?

A

CML - bone marrow and blood cells contain the Philadelphia chromosome - t(9;22)

(this is basically a small chromosome 22 due to translocation between part of chromosome 9 and 22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is CML treated?

A

Tyrosine kinase inhibitors (TKIs) of BCR-ABL is first line:

  • Imatinib (Glivec)
  • Dasatinib (Sprycel)
  • Nilotinib (tasigna)
  • Bositinib
  • Ponatinib

Allogeneic stem cell transplantation is used in patients when TKIs fail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the myeloproliferative neoplasms (MPN)?

A

Polycythaemia vera (PV or PRV)

Essential thrombocythaemia (ET)

Myelofibrosis - often an advanced stage of PV and ET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical features of polycythaemia vera?

A

Headaches

Itch

Vascular occlusion

Thrombosis

Stroke, TIA

Splenomegaly

Just too much RBCs so they clog up easy^

17
Q

What are the laboratory features of polycythaemia vera?

A

Raised haemoglobin and haematocrit concerntrations

Tendancy for elevated WBCs and Platelets

elevated uric acid (& risk of gout)

elevated number of red cells

18
Q

How is polycthaemia vera treated?

A

Venesection (blood letting) to keep haematocrit <0.45

Aspirin - reduce risk of thrombosis

Cytoreduction - Hydroxycarbamide (HC) / alpha interferon

If HC fails - Ruxolitinib (JAK2 inhibitor)

19
Q

Describe the natural history of Polycythaemia vera (PV/PRV)

A

Stroke or other vascular event if poorly controlled

With time - the disease can progress to secondary myelofibrosis with bone marrow failure

With more time - it can further progress to AML

20
Q

What is essential thrombocythaemia?

What are its clinical features?

How is it treated?

A

Myeloproliferative disease with predominent feature of a raised platelet count

Symptoms of arterial and venous throombosis, digital ischaemia, gout, headaches, mild splenomegaly

Treatment: aspirin and hydroxycarbamide